✦ LIBER ✦

Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis

✍ Scribed by Soko Setoguchi; Daniel H. Solomon; Michael E. Weinblatt; Jeffrey N. Katz; Jerry Avorn; Robert J. Glynn; E. Francis Cook; Greg Carney; Sebastian Schneeweiss

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 80 KB
Volume: 54
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.22056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel tumor necrosis factor α–regulated

Novel tumor necrosis factor α–regulated genes in rheumatoid arthritis

✍ Huang-Ge Zhang; Karren Hyde; Grier P. Page; Jacob P. L. Brand; Juling Zhou; Shao 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

Risk of serious bacterial infections amo

Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists

✍ Jeffrey R. Curtis; Nivedita Patkar; Aiyuan Xie; Carolyn Martin; Jeroan J. Alliso 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## Objective To evaluate the risk of serious bacterial infections associated with tumor necrosis factor α (TNFα) antagonists among rheumatoid arthritis (RA) patients. ## Methods A retrospective cohort study of US RA patients enrolled in a large health care organization identified pat

Anti-tumor necrosis factor α switching i

Anti-tumor necrosis factor α switching in rheumatoid arthritis and juvenile chronic arthritis

✍ Favalli, Ennio Giulio ;Arreghini, Marco ;Arnoldi, Cristina ;Panni, Benedetta ;Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

COPD ϭ chronic obstructive pulmonary disease. 300 Letters \* RA ϭ rheumatoid arthritis; JRA ϭ juvenile rheumatoid arthritis; ESR ϭ erythrocyte sedimentation rate; CRP ϭ C-reactive protein; VAS ϭ visual analog scale; GH ϭ general health; DAS28 ϭ Disease Activity Score in 28 joints; HAQ ϭ Health Asses

Association between the level of circula

Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at −308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor

✍ Hubert Marotte; Béatrice Arnaud; Jennifer Diasparra; Saloua Zrioual; Pierre Mios 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

Tumor necrosis factor α 5′-flanking regi

Tumor necrosis factor α 5′-flanking region, tumor necrosis factor receptor II, and HLA–DRB1 polymorphisms in Japanese patients with rheumatoid arthritis

✍ Tsukasa Shibue; Naoyuki Tsuchiya; Tae Komata; Masaki Matsushita; Michiko Shiota; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Increased risk of coccidioidomycosis in

Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists

✍ Laurie Bergstrom; David E. Yocum; Neil M. Ampel; Isidro Villanueva; Jeffrey Liss 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

## Abstract ## Objective To describe a group of patients who were treated with tumor necrosis factor α (TNFα) antagonists and who developed coccidioidomycosis, and to test the hypothesis that patients with inflammatory arthritis receiving TNFα antagonist therapy are at higher risk for developing s